Apple Watch Series 9 and Apple Watch Ultra 2 sales ban to be reinstated from tomorrow
The Apple Watch Series 9 and Apple Watch Ultra 2 will once again be banned from sale in the US from tomorrow as part of an ongoing patent infringement dispute over the blood oxygen sensing technology in the two wearables.
The US Court of Appeals for the Federal Circuit on Wednesday officially denied Apple’s request to pause the sales ban, which entered effect in late December before being suspended temporarily a few days later.
When the ban is reinstated, Apple will be prohibited from selling the Apple Watch models equipped with blood oxygen sensing in the United States, although the company could be planning a workaround, by removing the feature from the devices to bypass the ban.
Masimo, a U.S.-based medical technology company, initiated a lawsuit against Apple, accusing the tech giant of infringing on patents related to blood oxygen sensing technology. This feature was first introduced with the Apple Watch Series 6 in 2020, providing users with information about the oxygen levels in their blood.
Apple has yet to comment on the ruling.